-The Business Standard Says licence terms extended to 15 years on advice of erstwhile Industrial Credit and Investment Corporation of India, a lender to many telcos Giving a clean chit to Prime Minister Manmohan Singh on the 2G spectrum allocation case in 2008, the Joint Parliamentary Committee (JPC) that looked into telecom spectrum allocations has turned the heat on the numerous decisions taken in the sector between 1998 and 2004, during...
More »SEARCH RESULT
Total Matching Records found : 3297
2G scam: JPC clears Manmohan Singh, Chidambaram; pins Rs 40,000 crore loss on NDA
-The Times of India Prime Minister Manmohan Singh has been given a clean chit by the Joint Parliamentary Committee on telecom which rubbished CAG's Rs 1.76 lakh crore loss calculations in the 2G scam but slammed the Vajpayee government for Rs 40,080 crore loss due to a policy shift in 1999. The committee - headed by Congress MP P C Chacko - in its draft report pinned the 2G blame on former...
More »Bihar spends Rs 170cr annually guarding VIPs -Gyan Prakash
-The Times of India PATNA: Bihar spends Rs 170 crore annually deploying 5,000 police personnel out a force of 60,000 as bodyguards for politicians, judges, bureaucrats, police officers, members of constitutional bodies and other governmental functionaries. The NDA Government in 2007 had created separate posts of 5,800 bodyguards which were later merged with the police. Patna district police has 1,500 such bodyguards. One constable used to be assigned to each MLA or MLC,...
More »Social Justice
KEY TRENDS • According to National Sample Survey report no. 583: Persons with Disabilities in India, the percentage of persons with disability who received aid/help from Government was 21.8 percent, 1.8 percent received aid/help from organisation other than Government and another 76.4 percent did not receive aid/ help *8 • As per National Family Health Survey-4 (NFHS-4), the Under-five Mortality Rate (U5MR) was 57.2 per 1,000 live births (for the non-STs it was 38.5)...
More »SC’s Novartis judgement renews focus on accessible medicine
The recent Supreme Court judgment dismissing pharma giant Novartis’ claim for patent protections in India for its award-winning and prohibitively priced anti-leukemia drug Glivec has renewed the focus on accessibly-priced drugs – in particular the failure of the Indian public healthcare system and health policy to ensure affordable drugs for all. Studies show that as much as 70% of health spending in India comes from out-of-pocket payments, with 50-80% of...
More »
